Teva Pharmaceutical Industries (TEVA) Gross Profit Growth (3y) (2012 - 2026)

Teva Pharmaceutical Industries (TEVA) Gross Profit Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (3y) (Qtr)
1 Haleon 90.13 Bn 88.27 Bn - -
2 Teva Pharmaceutical Industries 35.98 Bn 32.24 Bn 1.97 Bn 7.62%
3 Zoetis 32.59 Bn 30.65 Bn 1.62 Bn 4.71%
4 Takeda Pharmaceutical 27.55 Bn 23.49 Bn 4.39 Bn -7.64%
5 United Therapeutics 23.08 Bn 20.93 Bn 648.10 Mn 12.55%
6 RedHill Biopharma 21.48 Bn 21.48 Bn - -
7 Viatris 20.38 Bn 18.57 Bn 1.16 Bn -9.13%
8 Neurocrine Biosciences 17.80 Bn 16.48 Bn 800.70 Mn 24.80%
9 Elanco Animal Health 12.64 Bn 12.21 Bn 785.00 Mn 0.95%
10 Vireo Growth 10.51 Bn 10.36 Bn 59.30 Mn 83.99%

Historic Data

Download Data
DateValue
Mar 31, 2026 7.62%
Dec 31, 2025 14.49%
Sep 30, 2025 11.35%
Jun 30, 2025 5.42%
Mar 31, 2025 2.56%
Dec 31, 2024 1.14%
Sep 30, 2024 6.19%
Jun 30, 2024 2.62%
Mar 31, 2024 -1.94%
Dec 31, 2023 5.66%
Sep 30, 2023 -0.02%
Jun 30, 2023 0.62%
Mar 31, 2023 -8.47%
Dec 31, 2022 -3.31%
Sep 30, 2022 -3.02%
Jun 30, 2022 -1.77%
Mar 31, 2022 -2.13%
Dec 31, 2021 1.32%
Sep 30, 2021 -3.19%
Jun 30, 2021 -2.70%